You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

345 Results
Chercheur, Recherche en matière de surveillance, Soins aigus et hospitaliers, Santé Ontario todd.norwood@ontariohealth.ca  
Drug
Other Name(s): Imjudo®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Document
Jan 2025
Guidelines and Advice
Status: Current
ID: MOTAC-7
Jan 2025
Drug
Other Name(s): Trecondyv®
Quick Link(s): Drug Monograph
Jan 2025
Drug
Other Name(s): Lorbrena®
Quick Link(s): Drug Monograph, Patient Info Sheet
Feb 2025
Drug
Other Name(s): Tukysa™
Quick Link(s): Drug Monograph, Patient Info Sheet
Feb 2025
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    lorlatinib - For the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer.
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lorlatinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2025
Regimen
Cancer Type:
Lung, 
Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
tarlatamab (Compassionate)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2025
Dans tout l’Ontario, les centres de cancérologie, les hôpitaux et les cliniques proposent une vaste gamme de services de dépistage, de diagnostic et...

Pages